Mysore Petro Chemicals Limited (BOM:506734)
India · Delayed Price · Currency is INR 101.48
-0.07 (-0.07%)
At close: Feb 12, 2026
Mysore Petro Chemicals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 357.21 | 334.79 | 257.99 | 184.14 | 209 | 228.41 | |
Revenue Growth (YoY) | -13.34% | 29.77% | 40.10% | -11.89% | -8.50% | 76.00% |
Cost of Revenue | 364.07 | 319.62 | 247.35 | 176.19 | 198.88 | 215.49 |
Gross Profit | -6.86 | 15.16 | 10.64 | 7.95 | 10.12 | 12.91 |
Selling, General & Admin | 25.77 | 42.44 | 26.79 | 30.63 | 23.9 | 22.24 |
Other Operating Expenses | 24.92 | 6.06 | 2.63 | 12.53 | -11.8 | -12.26 |
Operating Expenses | 54.22 | 52.18 | 33.89 | 47.44 | 18.05 | 16 |
Operating Income | -61.08 | -37.02 | -23.25 | -39.48 | -7.92 | -3.08 |
Interest Expense | -0.75 | -0.66 | -1.08 | -5.08 | -2.53 | -3.4 |
Interest & Investment Income | 14.53 | 14.53 | 15.19 | 8.34 | 19.74 | 39.49 |
Earnings From Equity Investments | -9.12 | 143.81 | 52.28 | 264.62 | 349.94 | 248.87 |
Currency Exchange Gain (Loss) | 7.88 | 7.88 | -0.49 | - | - | - |
Other Non Operating Income (Expenses) | 0.05 | 0.05 | 0.75 | -0.42 | -0.03 | -0.01 |
EBT Excluding Unusual Items | -48.48 | 128.59 | 43.39 | 227.98 | 359.19 | 281.87 |
Gain (Loss) on Sale of Investments | 53.86 | 53.86 | 80.37 | 41.04 | 66.7 | -42.73 |
Gain (Loss) on Sale of Assets | -2.19 | - | 0.28 | - | - | - |
Other Unusual Items | 2.19 | 2.19 | - | - | - | - |
Pretax Income | 5.39 | 184.65 | 124.03 | 269.02 | 425.89 | 239.14 |
Income Tax Expense | 4.93 | 43.2 | 24.88 | 61.8 | 98.97 | 261.57 |
Earnings From Continuing Operations | 0.46 | 141.44 | 99.15 | 207.22 | 326.92 | -22.44 |
Earnings From Discontinued Operations | - | -111.01 | -24.44 | - | - | - |
Net Income | 0.46 | 30.43 | 74.71 | 207.22 | 326.92 | -22.44 |
Net Income to Common | 0.46 | 30.43 | 74.71 | 207.22 | 326.92 | -22.44 |
Net Income Growth | -93.85% | -59.27% | -63.94% | -36.61% | - | - |
Shares Outstanding (Basic) | 7 | 7 | 7 | 7 | 7 | 7 |
Shares Outstanding (Diluted) | 7 | 7 | 7 | 7 | 7 | 7 |
EPS (Basic) | 0.07 | 4.62 | 11.35 | 31.48 | 49.66 | -3.41 |
EPS (Diluted) | 0.06 | 4.62 | 11.35 | 31.48 | 49.66 | -3.41 |
EPS Growth | -94.28% | -59.30% | -63.95% | -36.61% | - | - |
Free Cash Flow | - | -73.76 | -184.8 | -32.36 | -29.6 | -49.78 |
Free Cash Flow Per Share | - | -11.20 | -28.07 | -4.92 | -4.50 | -7.56 |
Dividend Per Share | - | 2.000 | 2.500 | 2.500 | 2.500 | 2.000 |
Dividend Growth | - | -20.00% | - | - | 25.00% | - |
Gross Margin | -1.92% | 4.53% | 4.12% | 4.32% | 4.84% | 5.65% |
Operating Margin | -17.10% | -11.06% | -9.01% | -21.44% | -3.79% | -1.35% |
Profit Margin | 0.13% | 9.09% | 28.96% | 112.53% | 156.42% | -9.82% |
Free Cash Flow Margin | - | -22.03% | -71.63% | -17.57% | -14.16% | -21.80% |
EBITDA | -58.65 | -33.71 | -18.78 | -35.21 | -1.98 | 2.93 |
EBITDA Margin | -16.42% | -10.07% | -7.28% | -19.12% | -0.95% | 1.29% |
D&A For EBITDA | 2.43 | 3.31 | 4.48 | 4.27 | 5.94 | 6.02 |
EBIT | -61.08 | -37.02 | -23.25 | -39.48 | -7.92 | -3.08 |
EBIT Margin | -17.10% | -11.06% | -9.01% | -21.44% | -3.79% | -1.35% |
Effective Tax Rate | 91.54% | 23.40% | 20.06% | 22.97% | 23.24% | 109.38% |
Revenue as Reported | 456.12 | 433.7 | 379.89 | 270.04 | 321 | 319.08 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.